Biocorrx (BICX)
(Delayed Data from OTC)
$0.32 USD
-0.18 (-35.54%)
Updated Sep 20, 2024 12:17 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Biocorrx Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 4 | 5 | 6 | 8 | 6 |
Income After Depreciation & Amortization | -4 | -5 | -6 | -7 | -6 |
Non-Operating Income | 1 | 1 | 1 | 5 | 1 |
Interest Expense | 1 | 1 | 1 | 1 | 2 |
Pretax Income | -4 | -4 | -5 | -4 | -6 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -4 | -4 | -5 | -4 | -6 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -4 | -4 | -5 | -3 | -6 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -3 | -4 | -5 | -7 | -4 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 1 | 1 | 1 |
Income After Depreciation & Amortization | -4 | -5 | -6 | -7 | -6 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 8.34 | 7.20 | 6.49 | 5.38 | NA |
Diluted EPS Before Non-Recurring Items | -0.44 | -0.61 | -0.79 | -0.65 | NA |
Diluted Net EPS (GAAP) | -0.45 | -0.61 | -0.81 | -0.65 | -1.71 |
Fiscal Year end for Biocorrx Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.02 | 0.01 | 0.02 |
Cost Of Goods | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 |
Gross Profit | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
SG&A, R&D, and Dept/Amort Expenses | 1.38 | 0.97 | 0.83 | 0.97 | 0.96 |
Income After SG&A, R&D, and Dept/Amort Expenses | -1.38 | -0.97 | -0.82 | -0.96 | -0.95 |
Non-Operating Income | 0.66 | 0.10 | 0.15 | 0.30 | 0.21 |
Interest Expense | 0.52 | 0.37 | 0.29 | 0.21 | 0.19 |
Pretax Income | -1.23 | -1.24 | -0.97 | -0.87 | -0.92 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | -0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -1.23 | -1.24 | -0.97 | -0.87 | -0.92 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -1.22 | -1.24 | -0.97 | -0.87 | -0.92 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 9.46 | 8.76 | 8.63 | 8.54 | 8.46 |
Diluted EPS Before Non-Recurring Items | -0.13 | -0.14 | -0.11 | -0.10 | -0.11 |
Diluted Net EPS (GAAP) | -0.13 | -0.14 | -0.11 | -0.10 | -0.11 |